A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Inclusion Criteria

• •Inclusion:
• •HIV positive
• •Are at least 18 years old
• •Subject has not been treated for an active AIDS-defining opportunistic infection within 15 days of screening
• •HIV RNA level \> 1000 copies/mL
• •Previous therapy with at least one protease inhibitor, at least one non-nucleoside reverse transcriptase inhibitor and at least one nucleoside reverse transcriptase inhibitor
• •Exclusion:
• •Subject is pregnant or breast-feeding
• •Subject has received an investigational drug within 30 days prior to screening
• •Have a history of pancreatitis
• +2 more criteria